Hi all .. If memory serves me correctly. None of these patients would have qualified to be a part of any specific trial. Their health situation was not suitable- from my understanding. So taking that into consideration, if I am correct, this result is more than -outstanding.
Thinking:- from my reads and research- you do your own- I may be a little off track here.
-no more open heart surgery - maybe less costs ?
-no long delay in hospital beds- A real positive benefit for the health system.
-less danger of infection - only a small wound (near groin ????)
-seemed to me some (or all) patients felt much better in a very short time after procedure (close to immediately ???) Better blood flow.
-for use in younger patients
-Not sure if any medicine - tablets are necessary after procedure - for extended period.
-If necessary- way down track -another procedure can be performed.
- May be others I missed
Keep safe all - lots of interesting news to come.
- Forums
- ASX - By Stock
- AVR
- Ann: DurAVR First in Human Study 12 Month Results
AVR
anteris technologies global corp.
Add to My Watchlist
1.96%
!
$6.00

Ann: DurAVR First in Human Study 12 Month Results, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.00 |
Change
-0.120(1.96%) |
Mkt cap ! $92.99M |
Open | High | Low | Value | Volume |
$6.01 | $6.08 | $5.95 | $42.27K | 7.022K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100 | $6.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.08 | 260 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100 | 6.010 |
1 | 75 | 6.000 |
3 | 1921 | 5.850 |
1 | 857 | 5.830 |
1 | 900 | 5.780 |
Price($) | Vol. | No. |
---|---|---|
6.080 | 260 | 1 |
6.100 | 10 | 1 |
6.180 | 58 | 2 |
6.200 | 1000 | 1 |
6.400 | 130 | 1 |
Last trade - 14.46pm 26/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman & CEO
Hank Holland
Chairman & CEO
Previous Video
Next Video
SPONSORED BY The Market Online